164 related articles for article (PubMed ID: 8465839)
1. Hyperfiltration and conservation of renal function in hypertensive nephrosclerosis patients.
Lee HC; Mitchell HC; Van Dreal P; Pettinger WA
Am J Kidney Dis; 1993 Apr; 21(4 Suppl 1):68-74. PubMed ID: 8465839
[TBL] [Abstract][Full Text] [Related]
2. Long-term improvement in renal function after short-term strict blood pressure control in hypertensive nephrosclerosis.
Pettinger WA; Lee HC; Reisch J; Mitchell HC
Hypertension; 1989 Jun; 13(6 Pt 2):766-72. PubMed ID: 2544523
[TBL] [Abstract][Full Text] [Related]
3. Reversible renal insufficiency due to angiotensin converting enzyme inhibitors in hypertensive nephrosclerosis.
Toto RD; Mitchell HC; Lee HC; Milam C; Pettinger WA
Ann Intern Med; 1991 Oct; 115(7):513-9. PubMed ID: 1883120
[TBL] [Abstract][Full Text] [Related]
4. Adverse effect of the calcium channel blocker nitrendipine on nephrosclerosis in rats with renovascular hypertension.
Wenzel UO; Troschau G; Schoeppe W; Helmchen U; Schwietzer G
Hypertension; 1992 Aug; 20(2):233-41. PubMed ID: 1639466
[TBL] [Abstract][Full Text] [Related]
5. Autoregulation of total and zonal glomerular filtration rate in spontaneously hypertensive rats during antihypertensive therapy.
Wang X; Aukland K; Iversen BM
J Cardiovasc Pharmacol; 1996 Dec; 28(6):833-41. PubMed ID: 8961082
[TBL] [Abstract][Full Text] [Related]
6. Glomerular hyperfiltration in essential hypertension: hormonal aspects.
Regolisti G; Buzio C; Cavatorta A; De Martin L; Cavalli R; Perazzoli F; Coghi P; Cabassi A; Pucci F; Borghetti A
Acta Biomed Ateneo Parmense; 1992; 63(1-2):163-73. PubMed ID: 1340661
[TBL] [Abstract][Full Text] [Related]
7. Endothelin-1-induced vasopressor responses in essential hypertension.
Kaasjager KA; Koomans HA; Rabelink TJ
Hypertension; 1997 Jul; 30(1 Pt 1):15-21. PubMed ID: 9231815
[TBL] [Abstract][Full Text] [Related]
8. ACE inhibitors and appearance of renal events in hypertensive nephrosclerosis.
Segura J; Campo C; Rodicio JL; Ruilope LM
Hypertension; 2001 Sep; 38(3 Pt 2):645-9. PubMed ID: 11566948
[TBL] [Abstract][Full Text] [Related]
9. Hypertensive nephrosclerosis: update.
Luft FC
Curr Opin Nephrol Hypertens; 2004 Mar; 13(2):147-54. PubMed ID: 15202608
[TBL] [Abstract][Full Text] [Related]
10. Renal protective effect of long term antihypertensive therapy with enalapril.
Bauer JH; Reams GP
Drugs; 1988; 35 Suppl 5():62-71. PubMed ID: 2850905
[TBL] [Abstract][Full Text] [Related]
11. L-arginine reverses severe nephrosclerosis in aged spontaneously hypertensive rats.
Ono H; Ono Y; Frohlich ED
J Hypertens; 1999 Jan; 17(1):121-8. PubMed ID: 10100103
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hypertension in nondiabetic renal disease.
Toto RD; Mitchell HC; Pettinger WA
Curr Opin Nephrol Hypertens; 1994 May; 3(3):279-85. PubMed ID: 7922253
[TBL] [Abstract][Full Text] [Related]
13. Renal effects of felodipine in hypertensive patients with reduced renal function.
Herlitz H; Aurell M; Björck S; Granérus G
Drugs; 1985; 29 Suppl 2():192-7. PubMed ID: 3987548
[TBL] [Abstract][Full Text] [Related]
14. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
Bauer JH; Reams GP
J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
[TBL] [Abstract][Full Text] [Related]
15. Renal responses to angiotensin receptor antagonist and angiotensin-converting enzyme inhibitor in partially nephrectomized spontaneously hypertensive rats.
Okada H; Suzuki H; Kanno Y; Ikenaga H; Saruta T
J Cardiovasc Pharmacol; 1995 Oct; 26(4):564-9. PubMed ID: 8569216
[TBL] [Abstract][Full Text] [Related]
16. ACE inhibition prevents and reverses L-NAME-exacerbated nephrosclerosis in spontaneously hypertensive rats.
Ono H; Ono Y; Frohlich ED
Hypertension; 1996 Feb; 27(2):176-83. PubMed ID: 8567038
[TBL] [Abstract][Full Text] [Related]
17. Enalapril versus metoprolol in primary hypertension--effects on the glomerular filtration rate.
Aurell M; Bengtsson C; Björck S
Nephrol Dial Transplant; 1997 Nov; 12(11):2289-94. PubMed ID: 9394313
[TBL] [Abstract][Full Text] [Related]
18. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.
Chan JC; Ko GT; Leung DH; Cheung RC; Cheung MY; So WY; Swaminathan R; Nicholls MG; Critchley JA; Cockram CS
Kidney Int; 2000 Feb; 57(2):590-600. PubMed ID: 10652036
[TBL] [Abstract][Full Text] [Related]
20. Renoprotective effects of felodipine and/or enalapril in spontaneously hypertensive rats with and without L-NAME.
Francischetti A; Ono H; Frohlich ED
Hypertension; 1998 Mar; 31(3):795-801. PubMed ID: 9495263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
